EUVIMEDEUVIMED entdecken
Leserbrief

Asthma‐related death trends and biologics use for severe asthma in the super‐aged society of Japan

Keiko Kan-O iD

Respirology · 2024-06 · 29 (6) · 455-457

DOI: 10.1111/resp.14729 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Respirology, online erschienen am 23.04.2024. Verfasst von Keiko Kan-O. Beteiligte Einrichtung: Department of Respiratory Medicine, Tokyo Women's Medical University, Tokyo, Japan. Hauptthemen laut MEDLINE: Asthma, Biological Products. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaBiological ProductsHumansJapanMaleFemaleAgedAnti-Asthmatic AgentsMiddle AgedSeverity of Illness IndexAged, 80 and over

Stichwörter der Autor:innen

Japanasthma‐related deathsbiologicssevere asthmasuper‐aged society

Substanzen

Biological ProductsAnti-Asthmatic Agents

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Tokyo Women's Medical University, Tokyo, Japan.

ORCID-Profile: Keiko Kan-O

Zitieren

APA

Kan-O, K. (2024). Asthma‐related death trends and biologics use for severe asthma in the super‐aged society of Japan. Respirology, 29(6), 455-457. https://doi.org/10.1111/resp.14729

Vancouver

Kan-O K. Asthma‐related death trends and biologics use for severe asthma in the super‐aged society of Japan. Respirology. 2024;29(6):455-457. doi:10.1111/resp.14729

BibTeX
@article{KanO2024,
  author = {Kan-O, Keiko},
  title = {Asthma‐related death trends and biologics use for severe asthma in the super‐aged society of Japan},
  journal = {Respirology},
  year = {2024},
  volume = {29},
  number = {6},
  pages = {455--457},
  doi = {10.1111/resp.14729}
}
Kostenlos starten →